scanX
Home
Bliss GVS Pharma

Bliss GVS Pharma

134.72
+0.69
(0.51%)
Market Cap
1,419.03 Cr
EPS
7.23
PE Ratio
17.56
Dividend Yield
0.37 %
Industry
Healthcare
52 Week High
185.50
52 Week low
92.15
PB Ratio
1.40
Debt to Equity
0.11
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
 1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
Divis Laboratories
 5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
Cipla
 1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
Torrent Pharmaceuticals
 3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
Dr Reddys Laboratories
 1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
Mankind Pharma
 2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
Zydus Life Science
 899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
Lupin
 1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
Aurobindo Pharma
 1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
Abbott
 29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
3.85 %
Net Income Growth
6.39 %
Cash Flow Change
344.33 %
ROE
-2.75 %
ROCE
-2.81 %
EBITDA Margin (Avg.)
27.85 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
100
184
138
148
146
162
235
241
226
239
198
173
219
253
217
247
214
223
153
139
137
154
168
138
176
201
222
179
196
175
211
188
165
225
206
204
188
223
226
Expenses
60
132
104
95
101
126
187
182
161
179
148
164
165
187
177
212
163
185
115
117
110
120
126
115
134
167
256
147
150
148
158
179
135
158
157
199
149
176
181
EBITDA
40
51
34
52
46
36
48
60
65
61
50
9
55
66
40
35
51
38
39
21
27
35
42
23
42
35
-33
32
46
27
53
9
29
67
49
5
39
47
45
Operating Profit %
36 %
25 %
21 %
34 %
27 %
21 %
18 %
27 %
28 %
20 %
25 %
2 %
20 %
18 %
20 %
13 %
23 %
12 %
22 %
2 %
15 %
21 %
23 %
13 %
21 %
15 %
-18 %
12 %
21 %
14 %
23 %
3 %
15 %
26 %
22 %
-0 %
19 %
19 %
14 %
Depreciation
3
6
3
2
4
4
11
1
5
5
7
5
2
2
2
2
3
4
3
3
4
4
4
4
4
4
4
4
5
5
5
5
6
6
7
7
7
7
8
Interest
5
5
2
7
4
4
4
8
7
6
5
5
1
1
1
1
1
1
1
5
2
0
1
2
1
1
1
2
2
2
1
5
2
2
2
2
2
4
1
Profit Before Tax
33
41
31
43
41
36
38
60
56
52
39
-1
51
63
37
32
47
34
34
13
20
30
37
17
37
30
-39
27
39
20
47
-1
22
59
40
-4
30
36
36
Tax
13
13
7
15
13
15
17
18
19
12
13
12
12
21
9
13
14
3
9
8
4
8
10
8
11
8
10
3
12
4
18
-4
7
16
11
1
8
10
11
Net Profit
20
28
24
29
28
21
22
43
37
40
26
-14
39
42
27
19
33
31
26
6
17
22
28
8
26
22
-49
24
28
16
30
4
14
43
29
-5
22
26
26
EPS in ₹
1.89
2.23
2.15
1.71
2.67
2.46
2.02
3.21
2.05
4.93
1.74
-1.39
3.72
4.02
2.50
1.76
3.28
3.00
2.30
0.85
1.57
1.99
2.48
0.61
2.35
2.05
-4.83
1.90
2.48
1.33
2.68
0.34
1.41
4.06
2.64
-0.88
1.97
2.31
2.27
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
662
762
1,023
860
905
1,027
1,077
1,109
1,157
1,214
Fixed Assets
234
225
305
143
146
242
234
282
379
370
Current Assets
417
471
566
690
694
770
765
777
697
812
Capital Work in Progress
0
9
4
1
47
0
2
22
3
8
Investments
0
0
0
0
0
0
0
2
8
4
Other Assets
428
527
714
717
712
786
840
803
768
832
Total Liabilities
662
762
1,023
860
905
1,027
1,077
1,109
1,157
1,214
Current Liabilities
243
267
437
299
207
231
204
233
193
160
Non Current Liabilities
68
50
33
13
38
46
45
29
46
51
Total Equity
352
446
553
548
660
750
828
847
917
1,003
Reserve & Surplus
327
402
476
526
636
725
798
808
874
957
Share Capital
10
10
10
10
10
10
10
10
10
11
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-34
23
30
-11
-22
0
-2
9
3
-1
Investing Activities
-30
-50
-249
48
-79
-40
-45
-103
-6
-133
Operating Activities
38
113
290
18
40
47
64
136
34
152
Financing Activities
-42
-40
-10
-76
17
-6
-21
-24
-25
-21
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
33.31 %
33.24 %
33.19 %
33.14 %
33.14 %
34.51 %
34.55 %
34.46 %
35.04 %
35.12 %
35.06 %
34.97 %
34.97 %
34.90 %
34.82 %
35.10 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
16.31 %
0.00 %
14.73 %
13.25 %
12.13 %
13.51 %
DIIs
6.72 %
6.72 %
6.67 %
6.66 %
6.66 %
6.65 %
6.64 %
6.63 %
6.63 %
6.62 %
6.61 %
6.59 %
6.59 %
6.58 %
6.57 %
6.55 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.45 %
26.90 %
27.59 %
28.26 %
30.37 %
30.15 %
30.57 %
30.74 %
30.00 %
30.10 %
29.17 %
30.78 %
31.71 %
32.84 %
34.57 %
32.93 %
Others
36.52 %
33.14 %
32.55 %
31.95 %
29.84 %
28.69 %
28.24 %
28.18 %
28.33 %
28.15 %
12.84 %
27.66 %
12.00 %
12.43 %
11.92 %
11.91 %
No of Share Holders
28,543
39,999
42,742
41,080
45,866
46,327
45,753
44,983
43,041
42,182
43,234
40,758
45,157
44,737
52,937
49,558

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.6 1 1 0.5 0.5 0.5 0.5 0.5 0.00
Dividend Yield (%) 0.00 0.31 0.56 0.99 0.51 0.65 0.71 0.44 0.37 0.00

Corporate Action

Technical Indicators

Bearish
0
Neutral
0
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Fundamental Screeners
Technical Screeners
Candlestick Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.